DSTA4637S

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

BacteremiaHealthy Volunteer

Phase 1

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers

CompletedNCT02596399

Genentech, Inc.Healthy Volunteer

Start: 2015-11-29End: 2016-05-30Updated: 2018-03-06

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics

CompletedNCT03162250

Genentech, Inc.Bacteremia

Start: 2017-07-13End: 2020-01-15Updated: 2020-01-22

Related Papers

A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers.

2019-05-2473 citations